Don’t Miss This FREE Live Trading Summit

On May 8, a 25-year trading veteran reveals the “market maker” strategy that’s pinpointing gains as high as 197%, 317%, even 1,147% in 30 days or less.

Wed, May 8 at 10:00AM ET
 
 
 
 
Join for FREE
Psychedelic Stocks Icon

Psychedelic Stocks

Psychedelics, such as psilocybin and DMT, are a class of powerful psychoactive substances that affect mood and cognitive processes. While still federally illegal under U.S. law, some states have voted to partially decriminalize the substances. Meanwhile, companies like ATAI Life Sciences and Compass Pathways have taken the initiative of developing psychedelic drugs to treat disorders like PTSD and depression.

pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory

3 Pharma Stocks Could Be the Pills Your Portfolio Needs

These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.

stethoscope on a stock chart representing healthcare stocks to buy. Healthcare Stocks

3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition

Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.

psychedelic stocks

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

The increased understanding and widespread acceptance of mental health concerns have put psychedelic stocks in the spotlight.

Other industries you might be interested in

Marijuana leaf

Cannabis

Cross symbol representing healthcare

Healthcare

Icon depicting a DNA strand

Biotech

Recent Psychedelic Stocks Articles

Why Is MindMed (MNMD) Stock Up 32% Today?

By William White, InvestorPlace Writer
MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!

Why Is MindMed (MNMD) Stock Up 8% Today?

By Samuel O'Brient, InvestorPlace Reporter
MindMed and other psychedelic stocks are rising today on news of an FDA priority review. Here's what this means for MNMD stock and its peers.

Why Is Clearmind Medicine (CMND) Stock Down 24% Today?

By William White, InvestorPlace Writer
Clearmind Medicine stock is falling on Thursday after shares of CMND underwent a major rally yesterday on a meeting with regulators.

Why Is Clearmind (CMND) Stock Up 40% Today?

By Dana Blankenhorn, InvestorPlace Contributor
The jump in Clearmind sent its market cap to $6 million. The study of psychedelic compounds to treat mental illness is growing.

Why Is Clearmind Medicine (CMND) Stock Up 50% Today?

By Josh Enomoto, InvestorPlace Contributor
Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock.

Don’t Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher

By Matthew Farley, InvestorPlace Contributor
Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.

Hidden Gems: 3 Cannabis Stocks Flying Under the Radar

By Faisal Humayun, InvestorPlace Contributor
These are the overlooked cannabis stocks to buy at attractive levels as they represent companies poised for accelerated growth.

The 3 Most Undervalued Under-$1 Stocks to Buy in September 2023

By Tyrik Torres, InvestorPlace Contributor
Cheap valuations and prospects for future growth should get individual investors excited for these under-$1 stocks to buy.

3 Millionaire-Maker Cannabis Stocks to Hold Through Thick and Thin

By Faisal Humayun, InvestorPlace Contributor
These are the potential multibagger cannabis stocks to buy and hold as they represent companies with a optimistic growth outlook.

The 3 Best Psychedelic Stocks to Buy Now

By Alex Sirois, InvestorPlace Contributor
Psychedelic stocks promise to bring therapeutics to market that were taboo until recently and have huge upside.

LSDI Stock Alert: Lucy Scientific Soars on Product Launch Update

By Larry Ramer, InvestorPlace Contributor
Lucy Scientific Discovery announced that it would partner with Canadian nonprofit TheraPsil. This has sent LSDI stock rallying 30%.

3 High-Growth Penny Stocks to Consider Buying in April 2023

By Chris MacDonald, InvestorPlace Contributor
Here are three high-growth penny stocks long-term investors may want to keep on their watch list, or buy, in April.

Why Is Clearmind Medicine (CMND) Stock Up 45% Today?

By William White, InvestorPlace Writer
Clearmind Medicine (CMND) stock is taking off on Wednesday even without any recent news from the psychedelic medicine company.

Why Is Clearmind Medicine (CMND) Stock Up 47% Today?

By William White, InvestorPlace Writer
Clearmind Medicine (CMND) stock is on the rise with heavy trading Wednesday despite a lack of news from the psychedelic medicines company.

Why Is Mind Medicine (MNMD) Stock Up 26% Today?

By William White, InvestorPlace Writer
Mind Medicine (MNMD) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial of lysergide (LSD).

Why Is Clearmind Medicine (CMND) Stock Up 56% Today?

By William White, InvestorPlace Writer
Clearmind Medicine (CMND) stock is taking off on Tuesday with heavy trading despite a lack of news concerning the psychedelics company.

7 Cannabis Stocks That Can Make You a Millionaire as Legalization Spreads

By Ian Cooper, InvestorPlace Contributor
Cannabis stocks could see higher highs with several key catalysts, creating a potential $100 billion opportunity.

The 7 Most Promising Psychedelic Stocks to Buy in February

By Muslim Farooque, InvestorPlace Contributor
These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

The 3 Best Sectors to Invest in for 2023

By Alex Sirois, InvestorPlace Contributor
A blend of value and growth defines the best sectors to invest in for 2023. These three sectors best fit the definition.
Load More Articles